Stock analysis for Passage Bio Inc (PASG:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. The latest Passage Bio stock prices, stock quotes, news, and PASG history to help you invest and trade smarter. AST SpaceMobile Inc. $ ASTS % ; Generation Bio Co. $ GBIO % ; Bristol-Myers Squibb Co. $ BMY % ; Alnylam Pharmaceuticals, Inc. $ Find the latest analyst research, reports, and ratings for Passage Bio, Inc. Common Stock (PASG) at lu-st.online Passage Bio, Inc. (Nasdaq: PASG), a clinical stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases.
PASG's current price target is $ Learn why top analysts are making this stock forecast for Passage Bio at MarketBeat. The Company does not currently have a direct stock purchase plan. The Company's common stock can be purchased by contracting a securities broker of your choice. Genetic medicines company Passage Bio to offer million shares in IPO priced at $16 to $18 each. Can Indians buy Passage Bio Inc shares? Yes, Indians can invest in the Passage Bio Inc (PASG) from India. With INDmoney, you can buy Passage Bio Inc at 0. About PASSAGE BIO (PASG) ; Price / earnings ratio. x ; Today's range. $ - $ ; Debt / equity. x ; 52 week range. $ - $ ; 5 year debt / equity. stock performance, and corporate governance. Overview · News · Events and Presentations · Financials and Filings · Stock Information · Investor FAQs · Resources. Passage Bio Inc PASG:NASDAQ · Open · Day High · Day Low · Prev Close · 52 Week High · 52 Week High Date03/06/24 · 52 Week Low PASG Passage Bio · High. · Low. · Volume. K · Open. · Pre Close. · Turnover. K · Turnover Ratio. % · P/E (Static). Loss. Company Profile. Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. Passage Bio Inc. ; Volume, K ; Market Value, $M ; Shares Outstanding, M ; EPS (TTM), -$ ; P/E Ratio (TTM), N/A. Track Passage Bio Inc (PASG) Stock Price, Quote, latest community messages, chart, news and other stock related information.
The current price of PASG is USD — it has increased by % in the past 24 hours. Watch Passage Bio, Inc. stock price performance more closely on the. Stock Quote: NASDAQ GS: PASG ; Day's Open. $ ; Volume. , ; Intraday High. $ ; Intraday Low. $ ; Closing Price. $ Passage Bio Inc. ; Volume, K ; Market Value, $M ; Shares Outstanding, M ; EPS (TTM), -$ ; P/E Ratio (TTM), N/A. Passage Bio Inc stock price live, this page displays NASDAQ PASG stock exchange data. View the PASG premarket stock price ahead of the market session. Overview. Passage Bio is a clinical stage genetic medicines company on a mission to improve the lives of patients with neurodegenerative diseases. Passage Bio, Inc. (US:PASG) has 63 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These. Discover real-time Passage Bio, Inc. Common Stock (PASG) stock prices, quotes, historical data, news, and Insights for informed trading and investment. What was Passage Bio's price range in the past 12 months? Passage Bio lowest stock price was $ and its highest was $ in the past 12 months. Passage Bio (PASG) has a Smart Score of 6 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund.
Passage Bio, Inc., a genetic medicines company, develops gene therapies for central nervous system diseases. The average price target is $ with a high forecast of $ and a low forecast of $ The average price target represents a % change from the. Given the current short-term trend, the stock is expected to fall % during the next 3 months and, with a 90% probability hold a price between $ and. Passage Bio (NASDAQ:PASG) Stock, Analyst Ratings, Price Targets, Forecasts. Passage Bio Inc has a consensus price target of $8 based on the ratings of 8. Passage Bio, Inc. (lu-st.online): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Passage Bio, Inc. | Nasdaq: PASG.
Passage Bio, Inc. specializes in developing transformative gene therapies for rare monogenic central nervous system (CNS) diseases. What are. Passage Bio Stock (NASDAQ: PASG) stock price, news, charts, stock research, profile. Is Passage Bio (NASDAQ:PASG) In A Good Position To Invest In Growth? (Simply Wall St.) +%. May Passage Bio Inc. (PASG). Passage Bio, Inc NASDAQ: PASG is a genetic medicines company focused on developing transformative therapies for central nervous system.